TABLE 1.
Group | Glucose | Insulin | Glucagon | Epinephrine |
---|---|---|---|---|
mm | pm | pm | pm | |
Control | 7.1 ± 0.2 | 151 ± 28 | 165 ± 26 | 1.7 ± 0.4 |
Control + ME inhibitor | 7.1 ± 0.4 | 178 ± 42 | 167 ± 20 | 1.8 ± 1.0 |
Glucagon | 12.9 ± 1.3** | 423 ± 86* | 934 ± 222** | 2.0 ± 1.1 |
Glucagon + ME inhibitor | 14.2 ± 1.1*** | 529 ± 79** | 1012 ± 54**** | 2.9 ± 0.9 |
Epinephrine | 15.5 ± 1.8*** | 421 ± 51* | 262 ± 57§§ | 8.6 ± 1.1***§§§ |
Epinephrine + ME inhibitor | 13.5 ± 1.0*** | 461 ± 58* | 160 ± 14§§§§ | 10.9 ± 1.1§§§ |
*, p < 0.05;
**, p < 0.01;
***, p < 0.001;
****, p < 0.0001 versus control;
§§, p < 0.01;
§§§, p < 0.001;
§§§§, p < 0.001 versus glucagon. Data are means ± S.E. of n = 6 per group.